Navin K. Kapur, MD, FACC, FSCAI, FAHA, discusses how acute cardiac unloading limits infarct scar formation in the context of the DTU-STEMI Pilot trial and Pivotal trial.
Amir Kaki, MD, discusses large bore femoral and axillary closure techniques as well as vascular closure devices currently on the market and in the pipeline.
Rajiv Tayal, MD, discusses axillary access techniques for large bore procedures as well as other alternative access skills for advanced interventional operators.
This FAQ discusses the causes, incidence, and diagnosis of right heart failure and how the Impella RP with SmartAssist heart pump can support the right side of the heart.
The STEMI DTU pivotal trial is a prospective, multicenter, two-arm randomized controlled trial that plans to enroll 668 patients undergoing treatment for a STEMI heart attack.
Three intensivists discuss managing Impella patients in the CCU, focusing on weaning off inotropes, repositioning Impella, invasive monitoring, and use of Impella and ECMO.
Francesco Burzotta, MD, and Carlo Trani, MD, discuss the long-term outcome of the extent of revascularization in complex, high-risk patients indicated for Protected PCI.
Alexander Truesdell, MD, and Behnam Tehrani, MD, discuss improved outcomes after implementing a cardiogenic shock protocol at Inova Heart and Vascular Institute.
A preponderance of evidence from the FDA cVAD Study, Impella Quality Database and the physician-initiated NSCI study supports the recommendation that placing Impella 2.5® or Impella CP® pre-PCI improves outcomes.
